HDAC3 and Cognitive impairment: One study using a six-beam simplified GCRsim found that pharmacological HDAC3 inhibition reversed LTP deficits and restored behavioral performance, indicating that epigenetic modulation can mitigate GCR-induced cognitive impairments [160].